Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Authors: Ragon, Brittany Knick, Shah, Mithun Vinod, D’Souza, Anita, Estrada-Merly, Noel, Gowda, Lohith, George, Gemlyn, de Lima, Marcos, Hashmi, Shahrukh, Kharfan-Dabaja, Mohamed A., Majhail, Navneet S., Banerjee, Rahul, Saad, Ayman, Hildebrandt, Gerhard C., Mian, Hira, Abid, Muhammad Bilal, Battiwalla, Minoo, Lekakis, Lazaros J., Patel, Sagar S., Murthy, Hemant S., Nieto, Yago, Strouse, Christopher, Badawy, Sherif M., Al Hadidi, Samer, Dholaria, Bhagirathbhai, Aljurf, Mahmoud, Vesole, David H., Lee, Cindy H., Pawarode, Attaphol, Gergis, Usama, Miller, Kevin C., Holmberg, Leona A., Afrough, Aimaz, Solh, Melhem, Munshi, Pashna N., Nishihori, Taiga, Anderson, Larry D., Jr., Wirk, Baldeep, Kaur, Gurbakhash, Qazilbash, Muzaffar H., Shah, Nina, Kumar, Shaji K., Usmani, Saad Z.

Source: In Blood Advances 27 June 2023 7(12):2746-2757

Allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Authors: Magee, Gray, Ragon, Brittany Knick

Source: In Best Practice & Research Clinical Haematology June 2023 36(2)

Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study

Authors: Ragon, Brittany Knick, Odenike, Olatoyosi, Baer, Maria R., Stock, Wendy, Borthakur, Gautam, Patel, Keyur, Han, Lina, Chen, Helen, Ma, Helen, Joseph, Loren, Zhao, Yang, Baggerly, Keith, Konopleva, Marina, Jain, Nitin

Source: In Clinical Lymphoma, Myeloma and Leukemia July 2019 19(7):431-440

Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.

Authors: Chojecki, Aleksander, Boselli, Danielle, Dortilus, Allison, Hamadeh, Issam, Begley, Stephanie, Chen, Tommy, Bose, Rupali, Podoltsev, Nikolai, Zeidan, Amer M., Balmaceda, Nicole Baranda, Yacoub, Abdulraheem, Ai, Jing, Knight, Thomas Gregory, Ragon, Brittany Knick, Shah, Nilay Arvind, Sanikommu, Srinivasa Reddy, Symanowski, James, Mesa, Ruben, Grunwald, Michael Richard

Source: Annals of Hematology; Aug2024, Vol. 103 Issue 8, p2837-2843, 7p

Subject Terms: POLYCYTHEMIA vera, RUXOLITINIB, MYELOFIBROSIS, ERYTHROCYTES, HEMATOCRIT, KINASE inhibitors, MYELOPROLIFERATIVE neoplasms

The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms

Authors: Ragon, Brittany Knick, Savona, Michael R.

Source: In Clinical Lymphoma Myeloma and Leukemia July 2017 17 Supplement:S37-S42

Geographic Distance Is Not Associated with Inferior Outcome When Using Long-Term Transplant Clinic Strategy

Authors: Ragon, Brittany Knick, Clifton, Carey, Chen, Heidi, Savani, Bipin N., Engelhardt, Brian G., Kassim, Adetola A., Vaughan, Leigh Ann, Lucid, Catherine, Jagasia, Madan

Source: In Biology of Blood and Marrow Transplantation January 2014 20(1):53-57

Impact of Race, Ethnicity, and Social Determinants of Heath on Outcomes for Acute Myeloid Leukemia Patients in a System with Specialized Nurse Navigation

Authors: Ragon, Brittany Knick, Boselli, Danielle ^*, Bose, Rupali ^*, Begley, Stephanie ^*, Aguiar, Melissa ^*, Blackley, Kris ^*, Shah, Nilay A. ^*, Chojecki, Aleksander L., Sanikommu, Srinivasa Reddy R., Ai, Jing, Druhan, Lawrence J, Steuerwald, Nury M, Patel, Jai N ^*, Symanowski, James T. ^*, Avalos, Belinda R., Copelan, Edward A., Raghavan, Derek ^*, Knight, Thomas G., Grunwald, Michael R.

Source: In Blood 15 November 2022 140 Supplement 1:10993-10995

Factors Predicting Efficacy and Toxicity of Post Transplantation Cyclophosphamide for Graft Versus Host Disease Prevention in Hematopoietic Cell Transplantation Recipients: Interim Data of an Ongoing Study

Authors: Chojecki, Aleksander L., Patel, Jai N. ^*, Foureau, David M, Symanowski, James ^*, Begic, Xhevahire ^*, Davis, Michael ^*, Steuerwald, Nury M, Norek, Sarah ^*, Sanikommu, Srinivasa Reddy R., Shah, Nilay A. ^*, Ragon, Brittany Knick, Knight, Thomas G., Ai, Jing, Grunwald, Michael R., Ghosh, Nilanjan, Druhan, Lawrence J, Avalos, Belinda R., Copelan, Edward A.

Source: In Blood 15 November 2022 140 Supplement 1:10534-10536

A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia

Authors: Fathi, Amir T., Fell, Geoffrey G ^*, El-Jawahri, Areej ^*, Perl, Alexander E., Jonas, Brian A., Dias, Ajoy L., Mims, Alice S., Borate, Uma, Ragon, Brittany Knick, Grunwald, Michael R., Peters, Mary Linton B. ^*, Graubert, Timothy A., Amrein, Philip C., Hock, Hanno R. ^*, Brunner, Andrew M., Hobbs, Gabriela S., Narayan, Rupa, Neuberg, Donna S., Aldoss, Ibrahim

Source: In Blood 15 November 2022 140 Supplement 1:3284-3286

MYC Pathway Upregulation Identified in Non-Responders to Hypomethylating Agents and Presents a Therapeutic Target in Acute Myeloid Leukemia

Authors: Ragon, Brittany Knick, Templeton, Margaret D., Seegers, Sara L., Chen, Jenny, Yang, Hsih-Te, Knight, Thomas G., Ai, Jing, Copelan, Edward A., Avalos, Belinda, Steuerwald, Nury M., Jin, Jian, Wang, Gang Greg, Park, Steven I., Patel, Jai N., Grunwald, Michael R., Druhan, Lawrence J.

Source: In Blood 2 November 2023 142 Supplement 1:5741-5741

Socioeconomic Disadvantage Is Associated with Decreased Long-Term Survival in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia

Authors: Verbyla, Allison, Boselli, Danielle, Ragon, Brittany Knick, Ai, Jing, Druhan, Lawrence J., Lin, Meng-Yun, Grunwald, Michael R., Hanchate, Amresh, Knight, Thomas G.

Source: In Blood 2 November 2023 142 Supplement 1:2391-2391

Enhanced Support Services Including Nurse Navigation Mitigate Socioeconomic Disparities in the Treatment of Patients with Acute Lymphoblastic Leukemia

Authors: Knight, Thomas G., Boselli, Danielle, Verbyla, Allison, Ai, Jing, Chojecki, Aleksander L., Shah, Nilay, Pang, Yifan, Druhan, Lawrence J., Copelan, Edward A., Grunwald, Michael R., Ragon, Brittany Knick

Source: In Blood 2 November 2023 142 Supplement 1:5078-5078

A Phase 1A/B Combination Study of Pegargiminase (ADI-PEG 20), Venetoclax and Azacitidine in Patients with Acute Myeloid Leukemia

Authors: Ragon, Brittany Knick, Bomalaski, John, Johnston, Amanda, Langlois, Mirla, Chang, Nicole DeFord, Borthakur, Gautam

Source: In Blood 2 November 2023 142 Supplement 1:1554-1554

Neighborhood Disadvantage Is Associated with Inferior Overall Survival for Acute Myeloid Leukemia Patients Treated with Standard Intensive Induction

Authors: Ragon, Brittany Knick, Boselli, Danielle, Bose, Rupali, Begley, Stephanie, Aguiar, Melissa, Blackley, Kris, Shah, Nilay, Chojecki, Aleksander L., Sanikommu, Srinivasa Reddy, Pang, Yifan, Ai, Jing, Avalos, Belinda, Copelan, Edward A., Knight, Thomas G., Grunwald, Michael R.

Source: In Blood 2 November 2023 142 Supplement 1:3799-3799

Self-Reported Distress Is Associated with Decreased Survival in Patients with Newly Diagnosed Acute Myeloid Leukemia

Authors: Knight, Thomas G., Symanowski, James T. ^*, Ai, Jing, Ragon, Brittany Knick, Chojecki, Aleksander L., Shah, Nilay A. ^*, Sanikommu, Srinivasa Reddy, Copelan, Edward A., Walsh, Declan ^*, Grunwald, Michael R., Meadors, Patrick L ^*

Source: In Blood 15 November 2022 140 Supplement 1:8144-8145

Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Authors: Patel, Jai N ^*, Lopes, Karine Eboli ^*, Druhan, Lawrence J, Zeng, Hang ^*, Beam, Travis ^*, Moore, Donald C ^*, Salem, Ahmed ^*, Hamadeh, Issam ^*, Savage, Quanisha ^*, Chojecki, Aleksander L., Ai, Jing, Knight, Thomas G., Ragon, Brittany Knick, Shah, Nilay A. ^*, Sanikommu, Srinivasa Reddy, Steuerwald, Nury M, Smith, Mathew ^*, Hamilton, Alicia ^*, Rangavajhula, Keerthana ^*, Bell, Ariel ^*, Drummond, Kendra ^*, Symanowski, James T. ^*, Grunwald, Michael R.

Source: In Blood 15 November 2022 140 Supplement 1:11530-11531

Measuring the Incidence of Distress and Supportive Oncology Utilization Among Patients with Myeloproliferative Neoplasms: A Single Center Experience

Authors: Patel, Rushil V., Boselli, Danielle ^*, Meadors, Patrick L ^*, Begley, Stephanie ^*, Bose, Rupali ^*, Ai, Jing, Ragon, Brittany Knick, Sanikommu, Srinivasa Reddy R., Shah, Nilay A. ^*, Knight, Thomas G., Symanowski, James T. ^*, Walsh, Declan ^*, Grunwald, Michael R., Chojecki, Aleksander L.

Source: In Blood 15 November 2022 140 Supplement 1:5279-5280

Acute Myeloid Leukemia Patients in Complete Remission with Positive Measurable Residual Disease Prior to Allogeneic Transplant Have Worse Outcomes, Similar to Active Disease Regardless of Conditioning Regimen Intensity and Post-Transplant Cyclophosphamide Administration

Authors: Tenneti, Pavan, He, Jiaxian, Ragon, Brittany Knick, Shah, Nilay A., Ai, Jing, Chojecki, Aleksander L., Knight, Thomas G., Avalos, Belinda, Copelan, Edward A., Grunwald, Michael R., Sanikommu, Srinivasa Reddy R.

Source: In Blood 23 November 2021 138 Supplement 1:4907-4907

Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies

Authors: Ragon, Brittany Knick, Moyo, Tamara K., Sumrall, Ashley, Osunkwo, Ifeyinwa (IFY), Blackley, Kris, Kabrich, Laura, Leonard, Kelly A., Masten, Ben, York, Beth, Murphy, Stephanie, Kersten, Brian, Batchelor, Thomas, Rivet, Carly, Parala-Metz, Armida, Shahid, Zainab, Chai, Jean, Musselwhite, Laura, Shah, Nilay A., Sanikommu, Srinivasa Reddy R., Chojecki, Aleksander L., Knight, Thomas G., Ai, Jing, Avalos, Belinda R, Grunwald, Michael R., Copelan, Edward A., Walsh, Declan

Source: In Blood 23 November 2021 138 Supplement 1:3019-3019

Clinical Characteristics and Outcomes of AML Patients Treated with Frontline CPX 351 or HMA/Venetoclax: A Single Institution's Experience

Authors: Chojecki, Aleksander L., Arnall, Justin, Boselli, Danielle, DiSogra, Kristyn Y., Karabinos, Allison, Chen, Tommy, Ai, Jing, Knight, Thomas G., Ragon, Brittany Knick, Shah, Nilay A., Sanikommu, Srinivasa R., Symanowski, James T, Avalos, Belinda R, Copelan, Edward A., Grunwald, Michael R.

Source: In Blood 23 November 2021 138 Supplement 1:1252-1252